Viridian Therapeutics Inc (NASDAQ: VRDN) is 1.29% higher on its value in year-to-date trading and has touched a low of $10.93 and a high of $24.18 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The VRDN stock was last observed hovering at around $20.70 in the last trading session, with the day’s gains setting it 1.36%.
Currently trading at $22.06, the stock is 40.99% and 45.62% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.23 million and changing 6.57% at the moment leaves the stock 33.78% off its SMA200. VRDN registered 31.70% gain for a year compared to 6-month loss of 27.88%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 55.57% gain in the last 1 month and extending the period to 3 months gives it a 67.76%, and is 56.56% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.15% over the week and 7.85% over the month.
Viridian Therapeutics Inc (VRDN) has around 96 employees, a market worth around $1.41B and $0.29M in sales. Profit margin for the company is -79185.76%. Distance from 52-week low is 101.92% and -8.77% from its 52-week high. The company has generated returns on investments over the last 12 months (-37.77%).
The EPS is expected to grow by 27.08% this year.
Viridian Therapeutics Inc (VRDN) Top Institutional Holders
204.0 institutions hold shares in Viridian Therapeutics Inc (VRDN), with institutional investors hold 92.95% of the company’s shares. The shares outstanding are 63.89M, and float is at 55.56M with Short Float at 14.46%. Institutions hold 92.94% of the Float.
The top institutional shareholder in the company is FMR LLC with over 9.57 million shares valued at $124.55 million. The investor’s holdings represent 15.6686% of the VRDN Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 4.77 million shares valued at $62.1 million to account for 7.8129 of the shares outstanding. The other top investors are DEEP TRACK CAPITAL, LP which holds 3.92 million shares representing 6.4221% and valued at over $51.05 million, while VR ADVISER, LLC holds 6.3547 of the shares totaling 3.88 million with a market value of $50.51 million.
Viridian Therapeutics Inc (VRDN) Insider Activity
The most recent transaction is an insider purchase by Fairmount Funds Management LLC, the company’s Director. SEC filings show that Fairmount Funds Management LLC bought 476,190 shares of the company’s common stock on Jan 22 ’24 at a price of $21.00 per share for a total of $10.0 million. Following the purchase, the insider now owns 1.84 million shares.
